Expert Consultations: Real-World Answers

Psychotropic Drug Adherence – Interview

Published on July 1, 2022 Expired on July 1, 2025

Guest

Wegdan Rashad

To unlock this audio you need to become a Silver, Gold, Silver extended or Gold extended Member.

Check Our CME Program

Downloads for Offline Access

Download Audio File (MP3)

Interview Highlights

Adherence assessment is a continuous process, and evaluation for adherence should be done at every visit.
Scales, such as the Rating of Medication Influences (ROMI) or the Drug Attitudes Inventory, may be helpful in exploring suboptimal adherence and possible reasons behind this.
A collaborative approach is recommended in identifying and targeting issues related to suboptimal adherence.

Text Version

This edition of Psychopharmacology Institute’s Expert Consultations features Martha Sajatovic, M.D., a professor of psychiatry and neurology at the Case Western Reserve University School of Medicine and the University Hospitals of Cleveland in Cleveland, Ohio. Dr. Sajatovic's research and clinical interests focus on neuropsychiatric outcomes of brain disorders across the lifespan, including dementia and Parkinson's disease. She also has research interests in self-management of chronic health conditions, health disparities

Unlock this Expert Consultation and earn 0.50 CMEs
Become a Silver, Gold, Silver extended or Gold extended Member.

Get Instant Access

Already have an account? Sign in

Learning Objectives:

After completing this activity, the learner will be able to:

Recognize the importance of assessing for psychotropic drug adherence in each patient visit.
Determine appropriate strategies for addressing suboptimal adherence among patients taking psychotropic medications.

Original Release Date: July 1, 2022

Review and Re-release Date: March 1, 2024

Expiration Date: July 1, 2025

Expert: Martha Sajatovic, M.D.

Medical Editors: Wegdan Rashad, M.D., Melissa Mariano, M.D.

Relevant Financial Disclosures:

Martha Sajatovic declares the following interests:

- Nuromate: Research grants

- Otsuka: Research grants, consultant

- International Society for Bipolar Disorders (ISBD): Research grants

- National Institutes of Health (NIH): Research grants

- Centers for Disease Control and Prevention (CDC): Research grants

- Patient-Centered Outcomes Research Institute (PCORI): Research grants

- Alkermes: Consultant

- Sunovion: Consultant

- Janssen: Consultant

- Lundbeck: Consultant

- Teva: Consultant

- Clinical Education Alliance: Consultant

- Springer Press: Royalties

All of the relevant financial relationships listed above have been mitigated by Medical Academy and the Psychopharmacology Institute.

Contact Information: For questions regarding the content or access to this activity, contact us at support@psychopharmacologyinstitute.com

Instructions for Participation and Credit:

Participants must complete the activity online during the valid credit period that is noted above.

Follow these steps to earn CME credit:

View the required educational content provided on this course page.
Answer the quiz for promoting retention of knowledge.
Complete the Post Activity Evaluation for providing the necessary feedback for continuing accreditation purposes and for the development of future activities. NOTE: Completing the Post Activity Evaluation after the quiz is required to receive the earned credit.
Download your certificate.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

Medical Academy designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Martha Sajatovic, M.D.